Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Correspondence] Routine molecular profiling of patients with NSCLC – Authors’ reply

We thank Verena Schildgen and Oliver Schildgen for their thoughtful and critical comment on our report.1 We agree that our paper mainly reflects the French national programme for biomarkers in lung cancer and thus cannot be extensively extrapolated to other countries and other health systems. Our aim was to provide basic data for a large number of patients (the largest cohort published so far) rather than in-depth analysis for selected patients. We provide a clear and unbiased picture of the incidence of six major biomarkers in daily practice patients.